Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
535 participants
OBSERVATIONAL
2009-01-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ID & Testing in Male Partners
NCT01033812
Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young Adults
NCT01203332
Engaging Care for HIV-infected Adolescent Females.
NCT00489034
Intervention for Newly Diagnosed Youth With HIV
NCT00510237
Transitioning HIV+ Adolescents to Adult Care: Exploring Adolescent and Adult Medicine Clinics Role in the Process
NCT02785302
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Index recruiters will be given up to four months to recruit members of their friendship network. At the end of this recruitment period or after successful recruitment of two or more friendship network members, whichever comes first, all index recruiters will be asked to complete a brief questionnaire that describes factors that both facilitated and hindered their ability to recruit the friendship network members. Sexually experienced friendship network members who agree to participate in the study will also complete a risk assessment regardless of whether or not they agree to undergo HIV screening. Participation in this study will be strictly on a voluntary basis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIV Positive
Participant self-discloses as HIV positive.
Sexually experienced females between the ages of 13 and 24 years old and of African American race, Hispanic/Latina ethnicity, or mixed-race/ethnicity, which must include African American race and/or Hispanic/Latina ethnicity.
Index Recruiter
Participants agree to recruit at least two female friends from their friendship network to undergo HIV screening.
HIV Negative
Participant self-discloses as HIV negative (based on receiving a negative HIV test within 12 months prior to study consent).
Sexually experienced females between the ages of 13 and 24 years old and of African American race, Hispanic/Latina ethnicity, or mixed-race/ethnicity, which must include African American race and/or Hispanic/Latina ethnicity.
Index Recruiter
Participants agree to recruit at least two female friends from their friendship network to undergo HIV screening.
HIV Status Unknown
Participant self-discloses as HIV negative (no history of prior HIV testing, or HIV screening more than 12 months prior to date of study consent).
Sexually experienced females between the ages of 13 and 24 years old and of African American race, Hispanic/Latina ethnicity, or mixed-race/ethnicity, which must include African American race and/or Hispanic/Latina ethnicity.
Index Recruiter
Participants agree to recruit at least two female friends from their friendship network to undergo HIV screening.
Friendship Network Members
Friendship network members will also consist of sexually experienced females, aged 13 years and older. Although most members are expected to be of African American race and/or Hispanic/Latina ethnicity, all races and ethnicities will be included.
Friendship Network Member
Participants are recruited by Index Recruiters to enroll in study and receive HIV screening and complete a questionnaire either on Facilitators of HIV Screening or Barriers to HIV Screening.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Index Recruiter
Participants agree to recruit at least two female friends from their friendship network to undergo HIV screening.
Friendship Network Member
Participants are recruited by Index Recruiters to enroll in study and receive HIV screening and complete a questionnaire either on Facilitators of HIV Screening or Barriers to HIV Screening.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 13-24 years at the time of consent;
* African American or Hispanic/Latina ethnicity or mixed-race/ethnicity, which must include African American race and/or Hispanic/Latina ethnicity;
* A history of sexual intercourse with at least one male sexual partner;
* Any HIV status as follows: (1) HIV positive; (2) HIV negative defined as receiving a negative HIV test result \< 12 months prior to the date of study consent); or (3) HIV status unknown defined as either no history of HIV testing or receipt of negative HIV test results more than 12 months prior to the date of study consent);
* History of vaginal and/or anal sexual intercourse with a male;
* Willing to complete a HIV risk assessment; and
* Willing to recruit two or more friendship network members to discuss and eventually undergo HIV screening;
* Ability to understand written and spoken English; and
* Willing to provide written informed consent/assent.
* Born female;
* Aged \> 13 years at the time of consent;
* A history of sexual intercourse with at least one male sexual partner;
* Willing to complete an HIV risk assessment;
* Willing to discuss and consider HIV screening;
* Self-report that the most recent HIV test result was negative, or has no prior history of HIV testing;
* Ability to understand written and spoken English; and
* Willing to provide written informed consent/assent.
Exclusion Criteria
* Visibly distraught and/or visibly emotionally unstable (e.g., depressive mood; exhibiting manic, suicidal, or violent behavior);
* Active drug or alcohol use or dependence that, in the opinion of the site personnel, would interfere with ability to give true informed consent and to adhere to the study requirements; and
* Acutely ill at the time of enrollment.
* Self-report an HIV positive test result;
* Psychiatric disorder (untreated) associated with thought disorder, hallucinations, acute substance use withdrawal. Stabilized patients receiving appropriate psychiatric care will not be excluded if informed consent can be reasonably assumed;
* Visibly distraught and/or visibly emotionally unstable (e.g., depressive mood; exhibiting manic, suicidal, or violent behavior);
* Active drug or alcohol use or dependence that, in the opinion of the site personnel, would interfere with ability to give true informed consent and to adhere to the study requirements;
* Acutely ill at the time of enrollment.
13 Years
24 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
National Institute of Mental Health (NIMH)
NIH
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cherrie B Boyer, PhD
Role: STUDY_CHAIR
University of California, San Francisco; ATN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami School of Medicine
Miami, Florida, United States
Stroger Hospital of Cook County
Chicago, Illinois, United States
Montefiore Medical Center
The Bronx, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
ATN Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ATN 067
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.